Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis.

Barriere, Paul; Porcu-Buisson, Géraldine; Hamamah, Samir

Barriere, Paul; Porcu-Buisson, Géraldine; Hamamah, Samir.

Affiliation

Barriere P; University Hospital of Nantes, 38 Boulevard Jean Monnet, 44093, Nantes Cedex, France.
Porcu-Buisson G; Reproductive Medicine Institute (IMR), 345, Avenue du Prado, 13008, Marseille, France.
Hamamah S; University Hospital of Montpellier - INSERM U1203, 371 Av. Du Doyen Gaston Giraud, 34295, Montpellier, France. s-hamamah@chu-montpellier.fr.

Appl Health Econ Health Policy ; 16(1): 65-77, 2018 Feb.

Article in En | MEDLINE | ID: mdl-29124676

Subject(s)

Fertilization in Vitro/economics; Follicle Stimulating Hormone/economics; Menotropins/economics; Cost-Benefit Analysis; Drug Costs; Female; Fertilization in Vitro/methods; Follicle Stimulating Hormone/therapeutic use; France; Health Care Costs; Humans; Markov Chains; Menotropins/therapeutic use; Recombinant Proteins/economics; Recombinant Proteins/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fertilization in Vitro / Follicle Stimulating Hormone / Menotropins Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Appl Health Econ Health Policy Journal subject: SAUDE PUBLICA / SERVICOS DE SAUDE Year: 2018 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google